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Conspicuous pathologic features of chronic liver allo-
graft rejection include bile duct loss and chronic obliter-
ative arteriopathy. A quantitative histometric analysis 
was performed to document the extent of bile duct loss, 
the size of the "vanished" ducts and the extent of chronic 
obliterative arteriopathy and to determine whether 
there was any relationship between chronic obliterative 
arteriopathy and bile duct loss. All failed liver allograft 
specimens with chronic rejection were reviewed and 
categorized according to the degree of chronic oblitera-
tive arteriopathy, assessed by the degree of luminal 
narrowing of hilar hepatic artery branches. Histometric 
analysis of the grafts revealed: (i) there was a loss of 
small portal arterioles «35 ~mF; (ii) bile ducts which 
should accompany arteries <35, 35 to 54 or 55 to 7 4 ~m 
in diameter were missing, with the greatest decrease 
occurring among the smallest ducts; (iii) bile duct loss 
was seen in the absence of significant large vessel 
chronic obliterative arteriopathy, and (iv) the severity 
of arteriole and bile duct loss, as well as the size of the 
vanished ducts, was directly proportional to the degree 
of chronic obliterative arteriopathy. Furthermore, the 
size of the "vanished" bile ducts in liver allografts ap-
peared to differ from the size of ducts destroyed in 
primary biliary cirrhosis. These studies offer indirect, 
but suggestive proof that two mechanisms are operative 
in the bile duct loss seen in chronic rejection: direct 
lymphocytotoxicity and ischemic damage. 
Chronic liver allograft rejection is responsible for at 
least 20% of the graft failures at the University of Pitts-
burgh. If early graft failures, which are often secondary 
to operative technical difficulties, are excluded, the figure 
approaches 50%. Generally accepted pathologic features 
of chronic liver allograft rejection include chronic oblit-
erative arteriopathy (COA) and bile duct loss (1-5). The 
mechanisms involved in the development of COA, the 
major long-term complication of all solid organ allo-
grafts, are presently unknown. It seems likely that "im-
mune injury" plays at least a partial role. Bile duct loss 
is thought to be due to direct lymphocytotoxic attack, 
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which seems reasonable considering the histologic ap-
pearance (1-7). However, ischemia has been largely over-
looked as a cofactor in the pathogenesis of bile duct 
injury. 
The sole blood supply of the biliary tract in man is 
derived from the hepatic artery (8, 9). Therefore, COA 
may contribute to bile duct damage and loss. We under-
took a histometric analysis of liver allografts which failed 
because of chronic rejection to determine whether there 
is any relationship between COA and bile duct loss. 
MATERIALS AA~ METHODS 
Source Material. Liver allografts 'Which failed because of 
chronic rejection between 1981 and 1987 were reviewed (n = 
28). The diagnosis of chronic rejection was based on a charac-
teristic clinical course and confirmed by histologic analysis of 
the removed failed allograft. Allografts with complications 
other than rejection (e.g. hepatitis) were excluded from the 
analysis. Normal control livers were selected from organs ob-
tained at autopsy from patients with no clinical or pathologic 
evidence of liver disease. Tissue sampling for histologic sections 
from failed allografts and from control livers was performed 
according to a predefined protocol (10). Three sections were 
taken from the hilum, two sections from the left lobe and three 
sections from the right lobe. All sections were cut at 3 ~m and 
routinely stained with hematoxylin and eosin. No special stain-
ing techniques were routinely employed. 
Analysis of the Degree of COA. The three sections 
taken from the hilum of each liver were examined blindly and 
independently by two of the authors (S. 0., A. J. D_) for the 
degree of narrowing of hepatic arterial branches and the per-
centage of vessels affected. Thereafter, each case was subjec-
tively scored on the basis of an overall assessment of the 
severity of the COA present. Specifically, deep hilar sections 
(10) from each case were examined. These sections contained 
first, second and third order branching arteries. If more than 
70% of the arteries were narrowed by more than 75%, the case 
was classified as "severe COA." Conversely, in "mild COA," 
more than 70% of the arteries showed less than 35 % narrowing. 
Because this methodology was somewhat subjective, cases in 
which the determination of COA was not completely obvious 
were excluded. Also, omission of intermediate cases would 
accentuate any possible differences between these groups, 
which might result in recognition of the role of ischemia in bile 
duct loss. An example of severe COA is shown in Figure 1. 
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FIG. 1. Cross-section of larger hilar artery with severe COA. Note 
the almost complete luminal obliteration by the subintimal foam cells. 
H & E, 150X. 
Selection of Cases. Three subgroups of patients were 
then identified based on the degree of COA: none (normal 
controls, n = 14), mild (n = 10) and severe (n = 8) COA. 
General patient data are shown in Table 1. The average age of 
allograft patients with mild COA was 31.9 ± 11 years compared 
to 12.6 ± 10 years for the patients with severe COA (p > 0.05). 
There was a greater number of adult female patients in the 
mild COA group and more male children in the severe COA 
group. Among the control patients, there were nine females and 
five males (average age: 62 years). None had any clinical or 
pathologic evidence· of hepatic disease or malfunction_ The 
average graft survival was shorter in those with severe COA 
(i.7 ± 5.6 months) compared to those v.ith mild COA (33.7 ± 
43.9 months) (p < 0.05). Complete major histocompatibility 
typing of both donor and recipient was available in only eight 
of the 18 cases analyzed. No particular trend was noted in this 
small sample. The results were not further included because of . 
the limited amount of data. All patients were maintained on 
baseline immunosuppression of cyclosporine and steroids. Ep-
isodes of acute cellular rejection were treated with a steroid 
bolus or recycling doses. If steroids were unsuccessful, OKT3 
(Onho Pharmaceuticals, Raritan, NJ) was llcsed. 
Histometric Analysis of Portal Arterial Size and Dis-
tribution. The presence or absence of any artery within the 
confines of the portal tract and the size of the largest (or only) 
anery in that tract was recorded. This assessment was repeated 
for all portal tracts in every section of the selected cases 
(average: 200 to 300 portal tracts per case). The size of the 
artery was determined by measuring the diameter of the vessel 
to the outer extent of the media using an ocular micrometer. 
Tangentially cut arteries were handled as follows. Most arteries 
were, to some extent, cut tangentially. If the artery of interest 
Was located in a portal tract, which was defined on all sides by 
a limiting plate, the shortest diameter was measured. This 
measurement is closest to the true vessel diameter. If, however, 
that portal tract was not defined on all sides by a limiting plate 
~nd ran longitudinally through the section, the artery was 
f~oredK The percentage of portal tracts with arteries and the 
SIze distribution of the largest (or only) artery was then calcu-
lated and tabulated. Recognition of portal tracts in the failed 
allografts was sometimes difficult because of the lack of easily 
identifiable architectural features (i.e. bile ducts and arteries). 
In these livers, the appearance of the connective tissue, partie-
u.larly surrounding the vein, and the location of cholestasis 
(Invariably present in failed allografts; centrilobular) were used 
TABLE 1. General data oC patients experiencing chronic liver 
allograft rejection 
OLT" Age Original Graft Degree Sex survival 
no. (years) disease" (mo) orCOA 
235 44 F PBC 3.0 Mild 
303 23 F CAH 1.3 Mild 
056 20 M CHF 140.5 Mild 
722 34 F PBC 4.0 Mild 
466 47 F HCC 6.3 Mild 
578 45 F PBC 6.2 Mild 
137 14 F CAH 71.5 Mild 
328 33 F PBC 39.5 Mild 
339 33 M PSC 24.7 Mild 
412 26 F CAH 40.7 Mild 
346 16 M Wilson's 2.0 Severe 
377 32 M PSC 14.8 Severe 
300 25 M HCC 3.7 Severe 
266 5 F A1ATD 2.0 Severe 
309 3 F 2°BC 7.0 Severe 
373 10 M SMN 7.7 Severe 
294 2 M A1ATD 17.0 Severe 
401 8 M SMN 7.7 Severe 
• OL T = orthotopic liver transplantation. 
b PBC = primary biliary cirrhosis; CAH = chronic active hepatitis 
(non-A, non-B); CHF = congenital hepatic fibrosis; HCC = hepatocel-
lular carcinoma; PSC = primary sclerosing cholangitis; A1ATD == ClI-
antitrypsin deficiency; 2°BC = secondary biliary cirrhosis; SMN = 
submassive necrosis. 
as landmarks. An example of a portal tract with no bile duct 
and no artery is shown in Figure 2. 
Histometric Analysis of Bile Duct Loss. We per-
formed an analysis similar to that done by Nakanuma and 
Ohta (11) to determine the extent of duct loss and the relative 
size of vanished bile ducts in the selected cases. In brief, it is 
known that arteries and bile ducts of a similar diameter occur 
in parallel in the portal tracts of normal livers. Precise meas-
urement of the greatest diameter (outer extent of media) of the 
largest (or only) artery in each portal tract was recorded. 
Tracing an imaginary circle 3 times the recorded arterial di-
ameter from the external media of that vessel circumscribed 
the area in which the accompanying bile duct should be de-
tected. An example of a portal tract which contains an artery, 
but no bile duct, is shown in Figure 3. The presence or absence 
of a bile duct within this area was then recorded for each portal 
tract of every section. The results were tabulated according to 
a predefined range of arterial diameter «35, 35 to 54, 55 to 74 
and ~ 75 /-Lm) for each liver and expressed as the rate of bile 
duct-artery (BD-A) parallelism. Arteries >75 /-Lm were not 
separated into distinct groups. Too few were present for a 
meaningful statistical analysis if subcategories were made. 
It must be noted that the rate of parallelism was determined 
only for those portal tracts which contained arteries. Portal 
tracts without arteries and bile ducts were excluded from the 
determinations of BD-A parallelism. 
RESULTS 
Pathologic Findings in Failed Liver Allo-
grafts. Grossly, the failed allografts with chronic re-
jection were slightly enlarged and bile stained. No graft 
was cirrhotic with grossly evident regenerative nodular-
ity. Hilar arteries had thickened walls. Microscopically, 
the lobular architecture was distorted secondary to portal 
and perivenular fibrosis. A true cirrhosis was not seen in 
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FIG. 2. Portal tract without an identifiable bile duct or artery. H & 
E,310x. 
FIG. 3. Portal tract containing an artery (arrowhead), but no bile 
duct. H & E, 500X. 
any of the livers. The fibrotic portal tracts were conspic-
uous for an absence of small bile ducts and arteries. A 
mild predominantly lymphohistiocytic and plasmacytic 
portal inflammatory infiltrate was scattered throughout 
the sections. Many portal tracts were free of inflamma-
tion. Often, the tracts without ducts were also devoid of 
inflammation. Centrilobular hepatocellular swelling was 
a conspicuous feature, and invariable prominent centri-
lobular hepatocanalicular cholestasis was present. First, 
second and third order branching vessels of the hepatic 
artery in the hilum demonstrated luminal narrowing 
secondary to subintimal foam cells and fibrointimal hy-
perplasia (COA). Intramural and periadventitial inflam-
mation was also present in some cases. The grafts were 
categorized according to the degree of COA, which is 
shown in Table 1. 
Distribution and Size of Portal Tract Arter-
ies. The percentage of portal tracts containing arteries 
or arterioles was computed for each of the 14 subjects 
with no COA (controls), the 10 subjects with mild COA 
and the eight subjects with severe COA (Fig. 4). Overall, 
90.9% of the portal tracts in controls, 61.3% of the portal 
tracts in cases with mild COA and 25.3% of the portal 
tracts in cases with severe COA had at least one artery 
or arteriole. The logistic regression model (12) was used 
to see whether there was an association between severity 
of COA and presence of arteries in the portal tract. A 
statistically significant (p < 0.001) association was found, 
with the differences between each pair of groups found 
to be significantly (p < 0.001) greater than zero. 
Figure 5 shows the percentage of portal tracts in which 
the largest or only artery is <35, 35 to 54, 55 to 74 or 
~TR .um in diameter for each subject, classified by degree 
of COA. Overall, the distribution of the size of the largest 
(or only) artery in those portal tracts with at least one 
artery is significantly (p < 0.001) different among groups, 
using the x2 test of association for independent samples. 
Pairwise comparison of the three groups (control, mild 
COA, severe COA) using the same statistical technique 
demonstrated that the distributions of the size of largest 
(or only) artery differ significantly (p < 0.001) between 
each pair of ~oupsK Among 81 % of the portal tracts of 
controls, the largest or only artery was less than 35 .um, 
compared to about 58% of the portal tracts in cases with 
mild COA and less than 41 % of the portal tracts in cases 
with severe COA. These differences are statistically sig-
nificant (p < 0.001). At the other extreme, only about 
4 % of the portal tracts in controls contained a single or 
largest artery 75 .um or greater in diameter, ranging from 
1.9 to 7.9% among the 14 subjects. This compares to 6% 
of portal tracts in cases with mild COA (range: 3.1 to 
12.6%) and over 14 % of portal tracts in cases with severe 
COA (range: 3.1 to 30.8%). These differences are also 
significant (p < 0.001). - -
Bile Duct-Arterial Parallelism. The mean rate 
of BD-A parallelism vs. arterial size, classified by degree 
of COA, is shown in Figure 6. Using a test for linear 
trend (13), there is a statistically significant (p < 0.001) 
trend toward decreasing parallelism with decreasing ar-
tery size in both the mild and severe COA groups. Using 
the x2 test for independent samples, statistically signifi-
cant differences (p < 0.01) for BD-A parallelism between 
groups (controls vs. mild COA, controls vs. severe COA 
and mild COA vs. severe COA) were found in all size 
categories, except between control and mild COA (p > 
0.05) for arteries greater than or equal to 75 .um in 
diameter. 
It must be remembered that the rate of BD-A paral-
lelism was determined using only those portal tracts 
which contained arteries. Bile duct loss with associated 
artery loss was not specifically tabulated. Therefore, 
absolute bile duct loss, particularly involving the smaller 
ducts «35 .um) is even greater than that expressed as a 
decrease in the rate of parallelism. 
DISCUSSION 
Analysis of the data reveals that quantifiable bile duct 
and small arterial loss are features of chronic liver allo-
graft rejection. The degree of damage to both arteries 
and bile ducts increases as the size of each decreases. 
Additionally, the severity and size of arterial loss and 
vanished ducts is directly proportional to the degree of 
COA. 
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Portal Tracts with Arteries 
I of Portal Tracts 
100 ....-----------..;-------------------, 
I . 80 t- ................................................................................................................... . 
I 
60 t-.................................................................................................................. . 
FIG. 4. The percentage of portal 
tracts from normal control and failed 
allograft livers containing at least one 
identifiable artery is represented. Note 
the absolute loss of identifiable portal 
arteries in failed allografts. 
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FIG. 5. The percentage of portal 
tracts according to the size of the largest, 
or only, portal artery is represented. 
Note the relative decrease in small portal 
arterioles and relative increase in larger 
arteries. 
o No Mild Severe No Mild Severe No MIld Severe No Mild Severe 
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Bile duct loss was recognizable under two circum-
stances. One occurred when an artery without a corre-
sponding bile duct was found (decreased rate of BD-A 
parallelism). The other was recognized when there was 
loss of both the artery and the bile duct (absolute arterial 
loss). Therefore, the results of this study offer indirect 
but supportive evidence that two mechanisms may be 
responsible for bile duct loss: direct immunologic attack 
and ischemic injury. 
The absence of a bile duct when an artery is found is 
supporting evidence for a direct (probably lymphocyto-
toxic) immunologic attack on the biliary epithelium. 
Other lines of evidence also point to a primary immu-
nologic insult upon the biliary epithelium. The histologic 
appearance of acute cellular rejection is characterized by 
lymphocytic invasion and evidence of degenerative 
changes in the biliary epithelium (1-7). Biliary inflam-
mation is less severe in chronic rejection (5, 10). Never-
theless, careful light microscopic examination of livers 
undergoing chronic rejection often reveals lymphocytic 
cells within the biliary epithelium. Ultrastructural ex-
amination of chronically rejected liver allografts by Fen-
nel and Vierling (14) revealed lymphocytes in close con-
tact with degenerating bile duct cells, similar to that 
necessary for cytotoxic T-lymphocyte reactions. In vitro 
functional analysis of graft-infiltrating lymphocytes also 
offers supportive evidence. Lymphocyte cultures gener-
ated from liver allograft tissue undergoing rejection have 
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Bile Duct-Artery Parallelism 
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FIG. 6. The percentage of portal 80 
tracts in which a bile duct is identified 
along with the corresponding artery is 
represented. Note the severe loss of 60 
small bile ducts in the failed allografts. 
Duct loss corresponding to larger arter-
ies is seen only in allografts with severe 
COA. Patients with PBC prior to trans- 40 
plantation are represented by the open 
circles. 
20 
o 
I Parallelisl 
-
I 
• 
0 
I f-
• e 
l- • • • 
.I. 
lID Mild ~ 
<35 Microns 
demonstrated cytotoxic activity directed at donor MHG 
antigens (15). These MHe antigens are expressed 
strongly on bile ducts (16, 17), particularly during a 
rejection reaction. 
The absence of a bile duct in conjunction with arterial 
loss is indirect but strongly suggestive evidence that 
ischemic injury contributes to duct loss. We also found 
that the severity of duct loss and the size of the "van-
ished" ducts is directly proportional to the degree of 
eOA. Since the biliary tree in man receives its blood 
supply exclusively from the hepatic arterial system (8, 
9), eOA and peripheral arterial loss compromise blood 
flow to the dependent bile ducts. Furthermore, the dam-
age to larger ducts seen in the allografts with severe eOA 
probably accounts for the biliary strictures detected by 
cholangiography in some patients with chronic rejection 
(10). Severe eOA and small arterial loss also help explain 
the appearance of hepatic arterial angiograms done in 
patients experiencing chronic liver rejection (18), with 
markedly narrowed main vessels, branch vessel occlu-
sions and no peripheral filling. 
The arterial damage seen in eOA may also be directly 
or indirectly lymphocyte mediated. Alternatively, small 
portal arteries may be subject to ischemic necrosis be-
cause of more proximal vessel occlusion. Moreover, these 
small arteries may be damaged by cytokines (e.g. TNF, 
IL-l) released in the portal tract during recurrent acute 
cellular rejection episodes. Regardless of the mechanism, 
the result is the same: diminished blood flow to bile 
ducts. 
One could argue that arterial and bile duct damage 
and loss occur in parallel, but not dependently. Although 
this line of reasoning is possible, we feel it is unlikely to 
be correct. First, as our evidence shows, severe duct loss 
was seen only in association with severe eOA. In fact, 
even when it appeared that large vessels were relatively 
unaffected by eOA, small peripheral artery loss was seen. 
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Secondly, it is known that arterial ischemia in nonallo-
graft livers may also produce bile duct loss (19). Thirdly, 
hilar bile duct strictures may occur in liver allografts 
with severe eOA, presumably due to an ischemic insult. 
Resolution may require the development of an animal 
model. Care must be taken, however, to ensure that the 
hemodynamics of such a model are analogous to the 
human liver allograft. . .. 
It is noteworthy that the patients with most severe 
eOA and bile duct loss had the shorter graft survival 
(Table 1, Fig. 6). This suggests that immunologic factors 
probably playa major role in the development of eOA. 
The results of this study also offer some insight into 
the puzzling question of whether primary biliary cirrhosis 
(PBe) recurs in liver allografts (20, 21). Nakanuma and 
Ohta (11) discovered that there was a decreased rate of 
BD-A parallelism for arteries 35 to 54, 55 to 74 and 75 
to 94 ~m in PBe livers, compared to controls. In contrast, 
we found that the loss of bile ducts in the liver allografts 
was more restricted. Only those ducts with corresponding 
arteries less than 75 ~m in diameter were missing. A 
decreased rate of BD-A parallelism for larger arteries 
was seen only when there was coexistent severe eOA. 
However, all of the patients transplanted for PBe in this 
study fell into the group with mild eOA. Therefore, none 
of the patients with PBe prior to transplantation who 
were included in this study demonstrated loss of larger 
ducts as shown by Nakanuma and Ohta (11). Further-
more, large excretory bile duct damage, similar to that 
seen in sclerosing cholangitis, is observed in liver allo-
grafts with eOA but not in PBe (21). Admittedly, we 
did not subdivide arteries >75 ~m as Nakanuma and 
Ohta have done. The reason for the different methodol-
ogy is outlined in the "Materials and Methods." 
Finally, the pathogenesis of graft eOA, or as some 
have termed it, "graft atherosclerosis," remains obscure. 
It is probable that many factors are involved, but we feel 
GY 
-------------
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that immunologic injury should be strongly considered, 
as originally suggested by Porter et a1. (22). Since COA 
is the major obstacle to long-term survival of heart (23), 
kidney (22) and liver (24) allografts, the attention of 
more transplant biologists should be focused on eluci-
dating the pathogenesis of this lesion (25, 26). 
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